Ocratoxins and their nephrotoxic potential
Abstract
Ochratoxins are fungal metabolites that are present in a wide variety of foods and their byproducts. Nephrotoxicity is its main toxic effect, related in turn to different clinical syndromes such as tubular necrosis or Balkan nephropathy. The information that is known about these substances comes from case reports, animal trials or in vitro experimental studies. This document offers an overview of ochratoxins, toxic mechanism, nephrotoxic effect, and a panorama of their current regulation in Colombia.References
Gil Á, Martinez de Victoria E, Olza J. Indicators for the evaluation of diet quality. Nutr Hosp. 2015;31(Suppl 3):128-44.
Wrigley C, Corke H, Seetharaman K, Faubion J. The Grains that Feed the World [Internet]. En: Encyclopedia of Food Grains. Elsevier, 2016. Disponible en: https://www.sciencedirect.com/referencework/9780123947864/encyclopedia-of-food-grains#book-description [citado: 07/04/2017].
Madrigal-Santillán E, Morales-González JA, Vargas-Mendoza N, Reyes-Ramírez P, Cruz-Jaime S, Sumaya-Martínez T, et al. Antigenotoxic studies of different substances to reduce the DNA damage induced by aflatoxin B(1) and ochratoxin A. Toxins (Basel). 2010;2(4):738-57.
Zain ME. Impact of mycotoxins on humans and animals. J Saudi Chem Soc. 2011;15(2):129-44.
International Agency for Research on Cancer. Ochratoxin A. IARC Monograp Eval Carcinog Hum. 1982;56:489-521.
Clark HA, Snedeker SM. Ochratoxin a: its cancer risk and potential
for exposure. J Toxicol Environ Health B Crit Rev. 2006;9(3):265-96.
Selvaraj JN, Lu X, Yan W, Yue-Ju Z, Fu-Guo X, Xiao-Feng D, Yang L. Mycotoxin detection-Recent trends at global level. J Integr Agric. 2015;14(11):2265-81.
Ravelo Abreu A, Rubio Armendáriz C, Gutiérrez Fernández AJ, Hardisson de la Torre A. La ocratoxina A en alimentos de consumo humano: revisión. Nutr Hosp. 2011;26(6):1215-26.
Heussner AH, Bingle LE. Comparative Ochratoxin Toxicity: a review of the available data. Toxins (Basel). 2015;7(10):4253-82.
Hope JH, Hope BE. A review of the diagnosis and treatment of
Ochratoxin A inhalational exposure associated with human illness and kidney disease including focal segmental glomerulosclerosis. J Environ Public Health. 2012;2012:835059.
Mally A, Hard GC, Dekant W. Ochratoxin A as a potential etiologic factor in endemic nephropathy: lessons from toxicity studies in rats. Food Chem Toxicol. 2007;45(11):2254-60.
Zhang J, Zhu L, Chen H, Li M, Zhu X, Gao Q, et al. A Polyketide Synthase Encoded by the Gene An15g07920 Is Involved in the Biosynthesis of Ochratoxin A in Aspergillus niger. J Agric Food Chem. 2016;64(51):9680-8.
Varga J, Kocsubé S, Péteri Z, Vágvölgyi C, Tóth B. Chemical, physical and biological approaches to prevent ochratoxin induced toxicoses in humans and animals. Toxins (Basel). 2010;2(7):1718-50.
Kamala A, Kimanya M, Lachat C, Jacxsens L, Haesaert G, Kolsteren P, et al. Risk of exposure to multiple mycotoxins from maize-based complementary foods in Tanzania. J Agric Food Chem. 2017;65(33):7106-14.
Mishra RK, Hayat A, Catanante G, Ocaña C, Marty JL. A label free aptasensor for Ochratoxin A detection in cocoa beans: An application to chocolate industries. Anal Chim Acta. 2015;889:106-12.
Pagkali V, Petrou PS, Salapatas A, Makarona E, Peters J, Haasnoot
W, et al. Detection of ochratoxin A in beer samples with a label-free monolithically integrated optoelectronic biosensor. J Hazard Mater. 2017;323(Pt A):75-83.
Tozlovanu M, Pfohl-Leszkowicz A. Ochratoxin A in roasted coffee from french supermarkets and transfer in coffee beverages: comparison of analysis methods. Toxins (Basel). 2010;2(8):1928-42.
Oteizaa JM, Khaneghahb AM, Campagnollo FB, Granato D, Mahmoudi MR, Sant’Anab AS, et al. Influence of production on the presence of patulin and ochratoxin A in fruit juices and wines of Argentina. LWT-Food Sci Technol. 2017;80:200-7.
Smith MC, Madec S, Coton E, Hymery N. Natural co-occurrence of mycotoxins in foods and feeds and their in vitro combined toxicological effects. Toxins (Basel). 2016;8(4):94.
Kőszegi T, Poór M. Ochratoxin A: molecular interactions, mechanisms of toxicity and prevention at the molecular level. Toxins (Basel). 2016;8(4):111.
Viter R, Savchuk M, Iatsunskyi I, Pietralik Z, Starodub N, Shpyrka N, et al. Analytical, thermodynamical and kinetic characteristics of photoluminescence immunosensor for the determination of Ochratoxin A. Biosens Bioelectron. 2018;99:237-43.
Müller G, Burkert B, Rosner H, Köhler H. Effects of the mycotoxin ochratoxin A and some of its metabolites on human kidney cell lines. Toxicol In Vitro. 2003;17(4):441-8.
Liew W-P-P, Mohd-Redzwan S. Mycotoxin: Its Impact on Gut Health and Microbiota. Front Cell Infect Microbiol. 2018;8:60.
Anzai N, Jutabha P, Endou H. Molecular mechanism of ochratoxin a transport in the kidney. Toxins (Basel). 2010; 2(6):1381-98.
Marin-Kuan M, Cavin C, Delatour T, Schilter B. Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms. Toxicon. 2008;52(2):195-202.
Dobritzsch D, Wang H, Schneider G, Yu S. Structural and functional characterization of ochratoxinase, a novel mycotoxin-degrading enzyme. Biochem J. 2014;462(3):441-52.
Vettorazzi A, González-Peñas E, de Cerain AL. Ochratoxin A kinetics: a review of analytical methods and studies in rat model. Food Chem Toxicol. 2014; 72:273-88.
Ravelo Abreu A, Rubio Armendáriz C, Gutiérrez Fernández AJ, Hardisson de la Torre A. La ocratoxina A en alimentos de consumo humano: revisión. Nutr Hosp. 2011; 26(6):1215-26.
Gupta RC, Lasher MA, Mukherjee IRM, Srivastava A, Lall R. Aflatoxins, Ochratoxins, and Citrinin. En: Reproductive and developmental toxicology / edited by Ramesh C. Gupta. 2nd ed. London: Elsevier, Academic Press, 2017, p. 945-62.
Žlender V, Breljak D, Ljubojević M, Flajs D, Balen D, Brzica H, et al. Low doses of ochratoxin A upregulate the protein expression of organic anion transporters Oat1, Oat2, Oat3 and Oat5 in rat kidney cortex. Toxicol Appl Pharmacol. 2009;239(3):284-96.
Gayathri L, Karthikeyan BS, Rajalakshmi M, Dhanasekaran D, Li AP, Akbarsha MA. Metabolism-dependent cytotoxicity of citrinin and ochratoxin A alone and in combination as assessed adopting integrated discrete multiple organ co-culture (IdMOC). Toxicol Vitr. 2018;46:166-77.
Žanić-Grubišić T, Zrinski R, Cepelak I, Petrik J, Radic B, Pepeljnjak S. Studies of Ochratoxin A-induced inhibition of phenylalanine hydroxylase and its reversal by phenylalanine. Toxicol Appl Pharmacol. 2000;167(2):132-9.
Sorrenti V, Di Giacomo C, Acquaviva R, Barbagallo I, Bognanno M, Galvano F. Toxicity of ochratoxin a and its modulation by antioxidants: a review. Toxins (Basel). 2013;5(10):1742-66.
Pfohl-Leszkowicz A, Manderville RA. An update on direct genotoxicity as a molecular mechanism of Ochratoxin A carcinogenicity. Chem Res Toxicol. 2012;25(2):252-62.
Murray AR, Kisin E, Castranova V, Kommineni C, Gunther MR, Shvedova AA. Phenol-induced in vivo oxidative stress in skin: evidence for enhanced free radical generation, thiol oxidation, and antioxidant depletion. Chem Res Toxicol. 2007;20(12):1769-77.
Stiborová M, Bárta F, Levová K, Hodek P, Frei E, Arlt VM, et al. The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats. Arch Toxicol. 2015;89(11):2141-58.
Jimenez AM, López de Cerain A, Gonzalez-Peñas E, Bello J, Betbeder AM, Creppy EE. Exposure to Ochratoxin A in Europe: comparison with a region of Northern Spain. J Toxicol Toxin Rev. 1998;17(4):479-91.
Malir F, Ostry V, Pfohl-Leszkowicz A, Roubal T. Ochratoxin A exposure biomarkers in the Czech Republic and comparison with foreign countries. Biomarkers. 2012;17(7):577-89.
Özçelik N, Koşar A, Soysal D. Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders. Toxicol Lett. 2001;121(1):9-13.
Grosso F, Saïd S, Mabrouk I, Fremy JM, Castegnaro M, Jemmali M, et al. New data on the occurrence of ochratoxin A in human sera from patients affected or not by renal diseases in Tunisia. Food Chem Toxicol. 2003;41(8):1133-40.
George B, You D, Joy MS, Aleksunes LM. Xenobiotic transporters and kidney injury. Adv Drug Deliv Rev. 2017;116:73-91.
Pavlović M, Plestina R, Krogh P. Ochratoxin A contamination of foodstuffs in an area with Balkan (endemic) nephropathy. Acta Pathol Microbiol Scand B. 1979;87(4):243-6.
Raghubeer S, Nagiah S, Chuturgoon AA. Acute Ochratoxin A exposure induces inflammation and apoptosis in human embryonic kidney (HEK293) cells. Toxicon. 2017;137:48-53.
Yang Q, Shi L, Huang K, Xu W. Protective effect of N-acetylcysteine against DNA damage and S-phase arrest induced by ochratoxin A in human embryonic kidney cells (HEK-293). Food Chem Toxicol. 2014;70:40-7.
Hennemeier I, Humpf HU, Gekle M, Schwerdt G. Role of microRNA-29b in the ochratoxin A-induced enhanced collagen formation in human kidney cells. Toxicology. 2014;324:116-22.
Shen XL, Zhang Y, Xu W, Liang R, Zheng J, Luo YB, et al. An
iTRAQ-based mitoproteomics approach for profiling the nephrotoxicity mechanisms of ochratoxin A in HEK 293 cells. J Proteomics. 2013;78:398-415.
Rodríguez-Iturbe B, Johnson RJ, Herrera-Acosta J. Tubulointerstitial damage and progression of renal failure. Kidney Int Suppl. 2005;99:S82-6.
Gan F, Zhou Y, Hou L, Qian G, Chen X, Huang K. Ochratoxin A induces nephrotoxicity and immunotoxicity through different MAPK signaling pathways in PK15 cells and porcine primary splenocytes. Chemosphere. 2017;182:630-7.
Stoev SD. Balkan Endemic Nephropathy - Still continuing enigma, risk assessment and underestimated hazard of joint mycotoxin exposure of animals or humans. Chem Biol Interact. 2017;261:63-79.
Costa JG, Saraiva N, Guerreiro PS, Louro H, Silva MJ, Miranda JP, et al. Ochratoxin A-induced cytotoxicity, genotoxicity and reactive oxygen species in kidney cells: an integrative approach of complementary endpoints. Food Chem Toxicol. 2016;87:65-76.
Müller G, Burkert B, Rosner H, Köhler H. Effects of the mycotoxin ochratoxin A and some of its metabolites on human kidney cell lines. Toxicol Vitr. 2003;17(4):441-8.
World Health Organization. Safety evaluation of certain contaminants in food. Prepared by the Sixty-fourth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). FAO Food Nutr Pap. 2006;82:1-778.
Kuiper-Goodman T. Risk assessment of ochratoxin A: an update. Food Addit Contam. 1996;13 Suppl:53-7.
Colombia. Ministerio de Salud y Protección Social, Fondo Colombiano de Enfermedades de Alto Costo. Situación de la enfermedad renal crónica, hipertensión arterial y diabetes mellitus en Colombia 2015 [Internet]. Bogotá, D.C., 2015. Disponible en:
https://cuentadealtocosto.org/site/images/Situaci%C3%B3n_de_la_Enfermedad_Renal_Cr%C3%B3nica_en_Colombia_2015.pdf [citado: 07/04/2017].
Krolewski AS, Skupien J, Rossing P, Warram JH. Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. Kidney Int. 2017;91(6):1300-11.
Textor SC. Renal arterial disease and hypertension. Med Clin North Am. 2017;101(1):65-79.
Coronel MB, Sanchis V, Ramos AJ, Marin S. Review. Ochratoxin A: presence in human plasma and intake estimation. Food Sci Technol Int. 2010;16(1):5-18.
El Khoury A, Atoui A. Ochratoxin A: general overview and actual molecular status. Toxins (Basel). 2010;2(4):461-93.
Van de Perre E, Jacxsens L, Lachat C, El Tahan F, De Meulenaer B. Impact of maximum levels in European legislation on exposure of mycotoxins in dried products: Case of aflatoxin B1 and ochratoxin A in nuts and dried fruits. Food Chem Toxicol. 2015;75:112-7.
Colombia. Ministerio de Salud y Protección Social. Resolución 4.506/2013 "Por la cual se establecen los niveles máximos de contaminantes en los alimentos destinados al consumo humano y se dictan otras disposiciones" [Internet]. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/resolucion-4506-de-2013.pdf [citado: 07/04/2017].
Jacob JT, Mehta AK, Leonard MK. Acute forms of tuberculosis in adults. Am J Med. 2009;122(1):12-7.
